Click it and Unblock the Notifications
Latest Updates
-
Meet Sheema Kermani: Pakistani Classical Dancer and Activist Detained During Aurat March Protest -
CBSE 12th Result 2026 Declared Today: Pass Percentage, Toppers, and Full Guide -
Vat Savitri Vrat 2026: 16th or 17th May? Significance, Vrat Katha, Rituals And Why Married Women Observe It -
Urvashi Rautela At Cannes 2026: Fifth Time, Silver Crystals And A Bird On Her Head -
Aloo Posto Recipe: Experience Bengali Authentic Taste -
Sonia Gandhi Hospitalised Again: What We Know About Her Admission To Medanta, Gurgaon -
Who Was Dileep Raj? Kannada Actor-Producer Passes Away At 47 After Sudden Heart Attack, Last Insta Post Viral -
Alia Bhatt On The Cannes Red Carpet: A Peach Tamara Ralph Gown And A Dupatta That Said It All -
PCOS Renamed PMOS: What It Is, Why It Matters, And What Changes Next -
Who Was Prateek Yadav? Former UP CM Mulayam Singh Yadav’s Younger Son Passes Away Suddenly At 38
Ebola Vaccine Found Safe In Humans Trials
Ebola vaccine has been recently found to be safe in human trials. Read to know.
An Ebola vaccine has been found to be safe and effective for children and adults in a clinical trial, producing an immune response against the deadly disease, say scientists including one of Indian origin. The worst Ebola virus disease outbreak in history ended in 2016 after infecting 28,600 people and killing about 11,300 worldwide.
It led to urgent action by medical experts across the world to combat this devastating disease; including the setting up of trials of vaccines to stop the disease taking hold. This global commitment to develop a vaccine against the disease suggested eight options, out of a starting pool of 15 candidates, should be evaluated in clinical trials worldwide by the end of 2015.
"An unprecedented Ebola outbreak showed how it is possible for academics, non-governmental organisations, industry and funders to work effectively together very quickly in times of medical crisis," said Sanjeev Krishna, of St George's University of London in the UK. "The results of the trial show how a vaccine could best be used to tackle this terrible disease effectively,"
Krishna said. Considering the persistent replication of the vaccine in children and adolescents, further studies investigating lower doses in this population are warranted. The vaccine contains a non-infectious portion of a gene from the Zaire Ebola virus. In addition, lower vaccine doses should be considered when boosting individuals with pre-existing antibodies to Ebola virus glycoprotein, a finding that has emerged after the vaccine was tested in a country that has experienced Ebolavirus outbreaks in the past.
The vaccine was one of two being examined as a 'candidate' option by the World Health Organization (WHO) to identify urgently a vaccine to combat the Ebola virus outbreak in West Africa.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.
Continue with Google